PhRMA Guidelines: Few Requirements, No Penalties

PhRMA's new direct-to-consumer voluntary advertising guidelines contain few requirements that will add to marketers' ethical and legal burdens in creating drug ads and does not add much to the trade group's July 21 statement that "encouraged" the industry to better target its audience, Adweek reports. There are no penalties for not following the guidelines and no mandatory ad-free time period between a drug's approval by the FDA and its consumer launch.